Your Health, We Care
Selinexor is the world's first orally administered selective nuclear export inhibitor (SINE) developed by the company. By blocking the function of nuclear export protein XPO1 (CRM1), it promotes the accumulation of tumor suppressor, growth regulator, and anti-inflammatory proteins in the nucleus, thereby enhancing its anti-cancer activity in cells.
